- Home
- JAZZ vs FLR Comparison
JAZZ vs FLR Comparison
Compare JAZZ & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- FLR
- Stock Information
- Founded
- JAZZ 2003
- FLR 1912
- Country
- JAZZ Ireland
- FLR United States
- Employees
- JAZZ N/A
- FLR N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- FLR Military/Government/Technical
- Sector
- JAZZ Health Care
- FLR Industrials
- Exchange
- JAZZ Nasdaq
- FLR Nasdaq
- Market Cap
- JAZZ 7.3B
- FLR 5.9B
- IPO Year
- JAZZ 2007
- FLR N/A
- Fundamental
- Price
- JAZZ $108.07
- FLR $41.56
- Analyst Decision
- JAZZ Strong Buy
- FLR Strong Buy
- Analyst Count
- JAZZ 13
- FLR 7
- Target Price
- JAZZ $181.85
- FLR $45.71
- AVG Volume (30 Days)
- JAZZ 1.3M
- FLR 3.6M
- Earning Date
- JAZZ 05-06-2025
- FLR 05-02-2025
- Dividend Yield
- JAZZ N/A
- FLR N/A
- EPS Growth
- JAZZ 49.21
- FLR 563.49
- EPS
- JAZZ 7.51
- FLR 10.64
- Revenue
- JAZZ $4,064,808,000.00
- FLR $16,563,000,000.00
- Revenue This Year
- JAZZ $5.92
- FLR $10.84
- Revenue Next Year
- JAZZ $4.22
- FLR $6.38
- P/E Ratio
- JAZZ $14.39
- FLR $3.91
- Revenue Growth
- JAZZ 5.76
- FLR 7.16
- 52 Week Low
- JAZZ $95.49
- FLR $29.20
- 52 Week High
- JAZZ $148.06
- FLR $60.10
- Technical
- Relative Strength Index (RSI)
- JAZZ 47.97
- FLR 64.16
- Support Level
- JAZZ $106.69
- FLR $37.34
- Resistance Level
- JAZZ $110.48
- FLR $43.86
- Average True Range (ATR)
- JAZZ 3.56
- FLR 1.36
- MACD
- JAZZ 0.55
- FLR 0.46
- Stochastic Oscillator
- JAZZ 68.77
- FLR 66.28
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About FLR Fluor Corporation
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.